跳到正文
← 返回论文列表与筛选
阅读说明

本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。

DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。

引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。

关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。

分类依据与纠错

AI 根据所提供的论文材料归类:摘要明确分析个体纵向结局曲线,并使用线性混合效应模型处理重复观测。

反馈分类问题

正在核对关联版本…

代码、数据与补充材料

正在核对对应版本的资源…

关注这篇论文的作者
Thaddeus Tarpey
Eva Petkova
Yimeng Lu
Usha Govindarajulu

线性混合效应模型的最优划分:识别安慰剂响应者

研究问题
如何根据临床试验中的纵向结局曲线识别典型响应轨迹,并利用随后随机停药阶段的复发情况研究这些轨迹的区分能力?
方法与思路
作者在可容纳连续与离散协变量的线性混合效应模型中实施最优划分,形成典型曲线,再对第二阶段复发时间进行生存分析。
材料陈述的贡献
摘要称,划分得到的典型轨迹能区分继续用药与改用安慰剂者的复发表现,并将该策略与增长混合模型作比较。
阅读关注点
应核对划分目标与组数选择、第一阶段开放治疗的作用,以及第二阶段随机化如何支持轨迹验证和安慰剂响应的解释。
阅读边界
仅据 OpenAlex 索引摘要,稿件版本未注明;划分稳定性和效应数值未说明,轨迹分组本身不能证明个体的药物或安慰剂因果响应。

原文摘要

A long-standing problem in clinical research is distinguishing drug treated subjects that respond due to specific effects of the drug from those that respond to non-specific (or placebo) effects of the treatment. Linear mixed effect models are commonly used to model longitudinal clinical trial data. In this paper we present a solution to the problem of identifying placebo responders using an optimal partitioning methodology for linear mixed effects models. Since individual outcomes in a longitudinal study correspond to curves, the optimal partitioning methodology produces a set of prototypical outcome profiles. The optimal partitioning methodology can accommodate both continuous and discrete covariates. The proposed partitioning strategy is compared and contrasted with the growth mixture modelling approach. The methodology is applied to a two-phase depression clinical trial where subjects in a first phase were treated openly for 12 weeks with fluoxetine followed by a double blind discontinuation phase where responders to treatment in the first phase were randomized to either stay on fluoxetine or switched to a placebo. The optimal partitioning methodology is applied to the first phase to identify prototypical outcome profiles. Using time to relapse in the second phase of the study, a survival analysis is performed on the partitioned data. The optimal partitioning results identify prototypical profiles that distinguish whether subjects relapse depending on whether or not they stay on the drug or are randomized to a placebo.

笔记与分组
相关领域论文